Safe switching from a pdFIX (Immunine®) to a rFIX (Bax326)

Haemophilia : the official journal of the World Federation of Hemophilia

Volumn 20, Issue 5, 2014, Pages 674-681

  Solano Trujillo, M H ^a   Stasyshyn, O ^a   Rusen, L ^a   Serban, M ^a   Lamas, J L ^a   Perina, F G ^a   Urasinski, T ^a   Oh, M ^a   Knowlton, W B ^a   Valenta Singer, B ^a   Pavlova, B G ^a   Abbuehl, B ^a  

^a HOSPITAL DE SAN JOSÉ   (Colombia)

Author keywords

haemophilia B; pdFIX (Immunine ); previously treated patients; rFIX (Rixubis ); safety

Indexed keywords

BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; COAGULATING AGENT; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; BLOOD; BLOOD CLOTTING; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECTS; DRUG SUBSTITUTION; FEMALE; HEMOPHILIA B; HEMORRHAGE; HUMAN; IMMUNOLOGY; INCIDENCE; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD COAGULATION; BLOOD COAGULATION FACTOR INHIBITORS; CHILD; COAGULANTS; CROSS-OVER STUDIES; DRUG SUBSTITUTION; FACTOR IX; FEMALE; HEMOPHILIA B; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 85027944865     PISSN: None     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12444     Document Type: Article

References (0)